First human trial of new experimental Ebola vaccine begin

Oxford University scientists begin to immunise volunteers Hope to immunise 72 adults by the end of the month to trial the new jab A prime injection is followed by a booster to strengthen immune response The vaccine wassuccessfulin protecting primates against Ebola There are now at least three Ebola vaccines being trialled for safety

By Madlen Davies for MailOnline

Published: 10:08 EST, 6 January 2015 | Updated: 12:54 EST, 6 January 2015

The first human trials of a new Ebola vaccine are today underway, the latest step in attempts to halt the spread of the virus in West Africa.

Scientists at Oxford University have immunised the first healthy volunteers with a new drug, which they hope will protect people against the disease.

The World Health Organisation said today more than 8,100 people have now lost their lives to the virus, the majority in Guinea, Sierra Leone and Liberia.

In September a separate trial was launched at the university, to test the effects of another potential vaccine.

The Oxford Vaccine Group, part of the University of Oxford Department of Paediatrics, aims to have vaccinated 72 healthy adult volunteers by the end of this month.

Oxford University scientists have begun immunising healthy volunteers in a trial of a new experimental Ebola vaccine. They hope to immunise 72 adults by the end of the month

The study involves a 'prime-boost' vaccine regime, meaning volunteers are given a first 'prime' injection to stimulate an initial immune response.

See more here:

First human trial of new experimental Ebola vaccine begin

Related Posts

Comments are closed.